Meyer Handelman CO Viatris Inc Transaction History

Meyer Handelman CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 06, 2022	SELL	$9.81 - $15.4 $231,094 - $362,777	-23,557 Closed	0 $0
Q4 2021 Jan 25, 2022	SELL	$12.09 - $14.68 $13,468 - $16,353	-1,114 Reduced 4.52%	23,557 $319,000
Q3 2021 Nov 01, 2021	SELL	$13.25 - $15.13 $7,777 - $8,881	-587 Reduced 2.32%	24,671 $335,000
Q2 2021 Aug 18, 2021	SELL	$12.97 - $16.15 $467,140 - $581,674	-36,017 Reduced 58.78%	25,258 $362,000
Q1 2021 May 03, 2021	SELL	$13.59 - $18.54 $1.28 Million - $1.75 Million	-94,384 Reduced 60.64%	61,275 $857,000
Q4 2020 Feb 03, 2021	BUY	$14.3 - $18.74 $2.23 Million - $2.92 Million	155,659 New	155,659 $2.92 Million

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Meyer Handelman CO, based on Form 13F filings with the SEC.

Stay updated on Meyer Handelman CO with notifications on news.